Genetic & rare diseases, Cellular & molecular biology, Corporate, Product

Video: European customers share their success stories

At ESHG in Vienna, Illumina representatives engaged with an impressive group of geneticists and entrepreneurs

European customers share their success stories
14 June 2022

Illumina teams proudly joined the 55th European Society of Human Genetics (ESHG) meeting in Vienna to support the research community in overcoming challenges in genomics and unlocking the power of the genome. A premier human genetics conference in Europe, attracting more than 3,500 delegates this year, ESHG promotes advancements in genetic research, drawing leading researchers, clinicians, academics, and pharmaceutical and biotechnology companies to forge new collaborations and foster education.

At ESHG, Illumina team members spoke with several customers to learn more about their genomic breakthroughs and vision for the future, particularly in the field of rare genetic diseases.

Customers are at the center of everything we do. The ESHG gives us a fabulous opportunity to listen to them and understand their needs, enabling transformational change in research and, ultimately, human health.

Recent Articles

When CGP uncovers potential hereditary cancer risk
When CGP uncovers potential hereditary cancer risk
Early access users rave about Illumina’s new MiSeq i100 Series
Early access users rave about Illumina’s new MiSeq i100 Series
Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments